This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Selective Serotonin Reuptake Inhibitor Add-On Therapy for the Negative Symptoms of Schizophrenia

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: I read with interest the recent meta-analysis by Sepehryet al.1 of selective serotonin reuptake inhibitor (SSRI) add-ontherapy for negative symptoms of schizophrenia and am concernedthat their negative conclusion largely reflects methodologicallimitations.The small number and heterogeneity of available studiesmake meta-analytic analyses at this time particularly vulnerableto confounds.2 Further, optimal use was not made of availablestudies: all participants in our original study3 received typicalantipsychotics (the only ones available then), a fact easily clarified,and thus were eligible for subanalyses of that group.’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 69

Quick Links: Schizophrenia and Schizoaffective Disorders